Upgrades:
Merck (MRK) upgraded to Outperform from Neutral at Credit Suisse; target $73
Downgrades:
JPMorgan Chase (JPM) downgraded to Neutral from Buy at Citigroup
Other:
Ao clicar em “OK”, você consente no uso de cookies. Leia nossa Política de Privacidade